As a research center embedded within Kaiser Permanente’s large and dynamic health care system, our investigators have a unique opportunity to apply scientific expertise to real-world clinical problems, translate findings into practice, and share what we learn with the broader community.
Dr. Rulin Hechter is an infectious disease epidemiologist in the Department of Research & Evaluation and an adjunct assistant professor of Epidemiology at the University of California, Los Angeles. Her research focuses on the prevention and treatment of HIV and other sexually transmitted infections. She also studies the impact of psychiatric disorders and substance abuse on health outcomes and care engagement among patients affected by other chronic comorbidities, including HIV/AIDS. Her ...
The physician ratings that patients see online may be inaccurate when compared to ratings compiled from surveys conducted internally by health care organizations, according to new research published today (Sept. 17, 2019) in the Journal of General Internal Medicine. “We know that patients often rely on online ratings when choosing doctors,” said Kanu Okike, MD, ...
The Senior Director of Research for Kaiser Permanente Southern California, Steven J. Jacobsen, MD, PhD, has been elected by his peers to the office of president-elect of the American College of Epidemiology (ACE) for the 2020 membership year. He will assume the College’s presidency in 2021. The election results were announced today (Sept. 10, 2019) ...
Researchers at the Department of Research & Evaluation are working to make the final life transitions better for patients and their families. Using analytical analysis, interviews, data queries and more, they aim to find out what people want in their final months and days, and how to improve care during that time. “The goal of ...
The National Institutes of Health has awarded Kaiser Permanente a grant to find a way to predict early-stage pancreatic cancer. Leading the project is principal investigator Bechien Wu, MD, MPH, a clinician investigator with the Department of Research & Evaluation and a gastroenterologist with the Kaiser Permanente Los Angeles Medical Center. “Pancreatic cancer is the ...
The physician ratings that patients see online may be inaccurate when compared to ratings compiled from surveys conducted internally by health care organizations, according to new research published today (Sept. 17, 2019) in the Journal of General Internal Medicine. “We know that patients often rely on online ratings when choosing doctors,” said Kanu Okike, MD, ...
Our inaugural IMPACT newsletter features stories on end-of-life research, the dangers of RSV in adults, a new grant to help predict early-stage pancreatic cancer, and more.
The Division of Clinical Trials Research advances medical innovation by supporting evaluation of new drugs, therapies, and devices to prevent and treat health problems. Our physician investigators work with cooperative groups and industry sponsors to conduct clinical trials for investigational drugs, biologics, and devices. In addition, the division develops pragmatic trials that help answer questions about care delivery.
The region has clinical trials programs in oncology (adult, gynecologic, pediatric, and surgical/radiation oncology), urology, gynecology, neurology, dermatology, metabolic diseases, nephrology, ophthalmology, infectious disease, cardiology, hepatology, vascular surgery, and rheumatology. Clinical trials staff support trials at medical centers and medical office buildings throughout the Kaiser Permanente Southern California Region.